neostigmine has been researched along with Anemia, Hemolytic in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martynova, VA | 1 |
| Savina, LS | 2 |
| Mikhaĭlova, EA | 1 |
2 other studies available for neostigmine and Anemia, Hemolytic
| Article | Year |
|---|---|
[Effect of cholinergic factors on the state of immunogenesis in animals with paroxysmal nocturnal hemoglobinuria-like hemolytic anemia].
Topics: Acetylcholine; Anemia, Hemolytic; Animals; Antibodies; Antibody Formation; Complement System Protein | 1980 |
[Importance of acetylcholinesterase in the development of hemolytic anemia].
Topics: Acetylcholine; Acetylcholinesterase; Anemia, Hemolytic; Animals; Dogs; Enzyme Activation; Erythrocyt | 1979 |